Clinical Trials Browser

Phase 2 × daromun × 90 days × Clear all

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Basal Cell